Cytokinetics (CYTK) Earnings Date, Estimates & Call Transcripts $54.36 -0.04 (-0.07%) (As of 09:57 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 8) -$1.33 Missed By -$0.17 Consensus EPS (May. 8) -$1.16 Read Call TranscriptListen to Call Get Cytokinetics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CYTK and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCYTK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CYTK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Chaikin Analytics50-year Wall Street Legend: “Prepare for a cash avalanche”The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the start of the year.So why are top hedge funds currently dumping their stocks? Cytokinetics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($1.33)($0.89)($1.14) Q2 20243($1.16)($1.05)($1.10) Q3 20243($1.19)($1.10)($1.16) Q4 20243($1.30)($1.25)($1.27) FY 202412($4.98)($4.29) ($4.68)CYTK Earnings Date and InformationCytokinetics last issued its quarterly earnings results on May 8th, 2024. The biopharmaceutical company reported ($1.33) earnings per share for the quarter, missing the consensus estimate of ($1.16) by $0.17. The company earned $0.84 million during the quarter, compared to the consensus estimate of $0.91 million. Its revenue was down 81.8% compared to the same quarter last year. Cytokinetics has generated ($5.40) earnings per share over the last year (($5.40) diluted earnings per share). Earnings for Cytokinetics are expected to grow in the coming year, from ($4.50) to ($4.28) per share. Cytokinetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Cytokinetics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/8/2024Q1 2024($1.16)($1.33)($0.17)($1.33)$0.91 million$0.84 million 2/27/2024Q4 2023($1.03)($1.38)($0.35)($1.38)$7.62 million$1.70 million 11/2/2023Q3 2023($0.72)($1.35)($0.63)($1.35)$24.71 million$0.38 million8/3/2023Q2 2023($1.23)($1.34)($0.11)($1.34)$5.67 million$0.87 million 5/4/2023Q1 2023($1.24)($1.38)($0.14)($1.38)$2.50 million$4.60 million 3/1/2023Q4 2022($1.22)($1.45)($0.23)($1.45)$7.10 million$1.96 million Get the Latest News and Ratings for CYTK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytokinetics and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022($1.19)($1.28)($0.09)($1.04)$2.26 million$2.52 million8/4/2022Q2 2022($1.04)($0.23)+$0.81($0.23)$3.73 million$88.97 million 5/4/2022Q1 2022($0.93)($1.02)($0.09)($0.99)$4.72 million$1.15 million 2/24/2022Q4 2021($0.89)($0.36)+$0.53($0.36)$5.56 million$55.60 million 11/3/2021Q3 2021($0.75)($0.95)($0.20)($0.95)$5.46 million$5.44 million 8/5/2021Q2 2021($0.66)($0.86)($0.20)($0.86)$5.68 million$2.84 million 5/6/2021Q1 2021($0.59)($0.66)($0.07)($0.66)$7.83 million$6.55 million 2/25/2021Q4 2020($0.48)($0.62)($0.14)($0.62)$4.10 million$6.72 million 11/4/2020Q3 2020($0.59)($0.05)+$0.54($0.05)$3.80 million$41.69 million 8/6/2020Q2 2020($0.57)($0.68)($0.11)($0.68)$4.80 million$3.59 million 5/6/2020Q1 2020($0.50)($0.66)($0.16)($0.66)$4.92 million$3.83 million 3/3/2020Q4 2019($0.44)($0.52)($0.08)($0.52)$7.19 million$5.21 million 10/31/2019Q3($0.56)($0.50)+$0.06($0.50)$7.80 million$6.06 million 8/8/2019Q2 2019($0.50)($0.56)($0.06)($0.56)$6.81 million$7.14 million Cytokinetics Earnings - Frequently Asked Questions When is Cytokinetics's earnings date? Cytokinetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on CYTK's earnings history. Did Cytokinetics beat their earnings estimates last quarter? In the previous quarter, Cytokinetics (NASDAQ:CYTK) missed the analysts' consensus estimate of ($1.16) by $0.17 with a reported earnings per share (EPS) of ($1.33). Learn more on analysts' earnings estimate vs. CYTK's actual earnings. How can I listen to Cytokinetics's earnings conference call? The conference call for Cytokinetics's latest earnings report can be listened to online. Listen to Conference Call How can I read Cytokinetics's conference call transcript? The conference call transcript for Cytokinetics's latest earnings report can be read online. Read Transcript How much revenue does Cytokinetics generate each year? Cytokinetics (NASDAQ:CYTK) has a recorded annual revenue of $7.53 million. How much profit does Cytokinetics generate each year? Cytokinetics (NASDAQ:CYTK) has a recorded net income of -$526.24 million. CYTK has generated -$5.40 earnings per share over the last four quarters. What is Cytokinetics's EPS forecast for next year? Cytokinetics's earnings are expected to grow from ($4.50) per share to ($4.28) per share in the next year. More Earnings Resources from MarketBeat Related Companies: PHAT Earnings ORIC Earnings NKTX Earnings KPTI Earnings BTAI Earnings TEVA Earnings GMAB Earnings BMRN Earnings RPRX Earnings BGNE Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Analysts and Earnings Propel the S&P 500's Continuous GrowthBlackBerry Stock: Strong Earnings, Profitability Challenges AheadWalgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts AheadAurora Cannabis Earnings Reveal a Turning Tide for the StockDarden Stock Up After Q4 Earnings Beat, Cautious FY25 OutlookAccenture’s Stock Earnings Reveal an AI-Powered Growth StrategySignet Jewelers Stock Poised for Rebound After Earnings Drop This page (NASDAQ:CYTK) was last updated on 7/5/2024 by MarketBeat.com Staff From Our Partners50-year Wall Street Legend: “Prepare for a cash avalanche”The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the star...Chaikin Analytics | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.